Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian E Smith

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Breast Cancer Research and Treatment|October 9, 2007
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patientsDavid S P Tan, Caterina Marchió, Robin L Jones, et al.
Breast Cancer Research and Treatment|July 2, 2008
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancerRobin L Jones, Janine Salter, Roger A'Hern, et al.
Breast (Edinburgh, Scotland)|September 28, 2010
Pattern of care in locally advanced breast cancer: focus on local therapyMarcin Sinacki, Andrzej Badzio, Marzena Wełnicka-Jaśkiewicz, et al.
Breast Cancer Research : BCR|June 23, 2006
The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysisSusan J Cleator, Trevor J Powles, Tim Dexter, et al.
Acta Oncologica (Stockholm, Sweden)|March 21, 2006
Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumabThomas Yau, Charles Swanton, Sue Chua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2013
Noninvasive detection of HER2 amplification with plasma DNA digital PCRHeidrun Gevensleben, Isaac Garcia-Murillas, Monika K Graeser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007
A phase II placebo-controlled trial of neoadjuvant anastrozole alone or with gefitinib in early breast cancerIan E Smith, Geraldine Walsh, Anthony Skene, et al.
Journal of the National Cancer Institute|January 18, 2007
Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancerMitch Dowsett, Ian E Smith, Stephen R Ebbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2013
Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistanceAnita K Dunbier, Zara Ghazoui, Helen Anderson, et al.
Breast Cancer Research : BCR|October 6, 2010
Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancerIsabel F Pinhel, Fiona A Macneill, Margaret J Hills, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Breast Cancer Research and Treatment|October 9, 2007
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patientsDavid S P Tan, Caterina Marchió, Robin L Jones, et al.
Breast Cancer Research and Treatment|July 2, 2008
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancerRobin L Jones, Janine Salter, Roger A'Hern, et al.
Breast (Edinburgh, Scotland)|September 28, 2010
Pattern of care in locally advanced breast cancer: focus on local therapyMarcin Sinacki, Andrzej Badzio, Marzena Wełnicka-Jaśkiewicz, et al.
Breast Cancer Research : BCR|June 23, 2006
The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysisSusan J Cleator, Trevor J Powles, Tim Dexter, et al.
Acta Oncologica (Stockholm, Sweden)|March 21, 2006
Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumabThomas Yau, Charles Swanton, Sue Chua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2013
Noninvasive detection of HER2 amplification with plasma DNA digital PCRHeidrun Gevensleben, Isaac Garcia-Murillas, Monika K Graeser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007
A phase II placebo-controlled trial of neoadjuvant anastrozole alone or with gefitinib in early breast cancerIan E Smith, Geraldine Walsh, Anthony Skene, et al.
Journal of the National Cancer Institute|January 18, 2007
Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancerMitch Dowsett, Ian E Smith, Stephen R Ebbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2013
Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistanceAnita K Dunbier, Zara Ghazoui, Helen Anderson, et al.
Breast Cancer Research : BCR|October 6, 2010
Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancerIsabel F Pinhel, Fiona A Macneill, Margaret J Hills, et al.
Pageof 14